Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name SNHG20
   Synonyms SNHG20, C17orf86, LINC00338, NCRNA00338, SCARNA16HG, PRO0872, FLJ25582, DKFZp686L05235
   Region GRCh38_17:77086716-77094990    Sequence
   Ensembl ENSG00000234912
   RefSeq NR_027058
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name colorectal cancer
   ICD-0-3 C19.9  
   Methods qPCR, RNAi, Western blot, Flow cytometry assay, Cell proliferation assay etc.
   Sample CRC tissues, cell lines (HCT8, HT29, HCT116, SW480, LOVO)
   Expression Pattern up-regulated
   Function Description

The results suggested that SNHG20 expression was significantly upregulated in CRC tissues compared to corresponding normal tissues from 107 CRC patients. High expression of SNHG20 was remarkably associated with advanced TNM stage in patients with CRC. Multivariate analyses unraveled that SNHG20 expression was an independent prognostic factor for overall survival in CRC patients. Further functional assays revealed that knockdown of SNHG20 suppressed cell proliferation, invasion and migration, and cell cycle progression in CRC cells. Moreover, SNHG20 regulated cell growth through modulation of a series of cell cycle-associated genes.

   Pubmed ID 27543107
   Year 2016
   Title Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer.
   External Links
   Links for  SNHG20 GenBank       HGNC       lncrnadb       Noncode
   Links for  colorectal cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.